Jevon Cutler

4PUBLICATIONS
38CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsDeep learningGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 08, 2026
CRISPR base editor screening identifies spectrum of MEN1 mutations impacting menin inhibitors in clinical trials.

|Aug 12, 2025
Dynamic extracellular interactions with AMPA receptors.

Hana Goldschmidt Merrion, Casey N Barber, Santosh S Renuse

|Jun 21, 2024
Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias.

Min Chul Kwon, Jan Willem Thuring, Olivier Querolle

|Dec 14, 2023
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML.

Wallace Bourgeois, Jevon A Cutler, Brandon J Aubrey

Pageof 1

Frequent Collaborators

3 joint publications

Daniela V Wenge

2 joint publications

Charlie Hatton

2 joint publications

Eric S Fischer

2 joint publications

Florian Perner